About Epigene Labs

Epigene Labs is a techbio company based in Paris, France, founded in 2019. The company specializes in precision oncology research and drug development, utilizing its AI-powered mCUBE platform. This platform integrates data from over 100,000 patient samples across more than 30 cancer types, enabling data-driven drug discovery, biomarker identification, and patient selection.

The mCUBE platform provides a comprehensive resource for harmonizing multi-dimensional oncology data, which supports faster research and development timelines and higher success rates in drug discovery. Epigene Labs also offers tailored datasets for identifying novel targets and validating biologics. The company is committed to advancing precision oncology through partnerships, such as with Institut Curie, and has achieved significant milestones, including the launch of a cancer patient data atlas and securing funding from notable investors.